Integral Diagnostics Ltd. (AU:IDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Limited has announced the cancellation of 14,152 performance rights securities (STI) on August 30, 2024, as a result of a mutual agreement between the company and the security holders. This significant update could influence the company’s capital structure and is likely of interest to investors tracking Integral Diagnostics’ financial movements.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.